Bank of New York Mellon
CABA icon

Bank of New York Mellon’s Cabaletta Bio CABA Stock Holding History

Bank of New York Mellon’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948K Buy
304,819
+250,520
+461% +$824K ﹤0.01% 3394
2026
Q1 		$146K Buy
54,299
+252
+0.5% +$700 ﹤0.01% 4058
2025
Q4 		$118K Buy
54,047
+6,237
+13% +$15.5K ﹤0.01% 4093
2025
Q3 		$112K Hold
47,810
– – ﹤0.01% 4094
2025
Q2 		$72.7K Sell
47,810
-107,364
-69% -$167K ﹤0.01% 4074
2025
Q1 		$215K Buy
155,174
+14,026
+10% +$29.9K ﹤0.01% 3860
2024
Q4 		$320K Sell
141,148
-16,945
-11% -$59.5K ﹤0.01% 3749
2024
Q3 		$746K Sell
158,093
-32,124
-17% -$186K ﹤0.01% 3296
2024
Q2 		$1.42M Buy
190,217
+44,156
+30% +$541K ﹤0.01% 2990
2024
Q1 		$2.49M Sell
146,061
-10,892
-7% -$234K ﹤0.01% 2655
2023
Q4 		$3.56M Buy
156,953
+11,486
+8% +$193K ﹤0.01% 2534
2023
Q3 		$2.21M Buy
145,467
+20,171
+16% +$276K ﹤0.01% 2758
2023
Q2 		$1.62M Buy
125,296
+99,555
+387% +$1.08M ﹤0.01% 2952
2023
Q1 		$213K Hold
25,741
– – ﹤0.01% 3894
2022
Q4 		$238K Buy
25,741
+6,919
+37% +$25.2K ﹤0.01% 3896
2022
Q3 		$12K Hold
18,822
– – ﹤0.01% 4490
2022
Q2 		$20K Sell
18,822
-3,852
-17% -$5.45K ﹤0.01% 4492
2022
Q1 		$46K Buy
22,674
+12,379
+120% +$32.4K ﹤0.01% 4534
2021
Q4 		$39K Hold
10,295
– – ﹤0.01% 4531
2021
Q3 		$125K Hold
10,295
– – ﹤0.01% 4288
2021
Q2 		$89K Sell
10,295
-40,435
-80% -$397K ﹤0.01% 4241
2021
Q1 		$563K Buy
50,730
+1,172
+2% +$14.3K ﹤0.01% 3622
2020
Q4 		$618K Sell
49,558
-1,949
-4% -$25.3K ﹤0.01% 3507
2020
Q3 		$558K Buy
51,507
+7,691
+18% +$88.4K ﹤0.01% 3439
2020
Q2 		$489K Buy
43,816
+22,765
+108% +$174K ﹤0.01% 3492
2020
Q1 		$154K Buy
21,051
+8,490
+68% +$116K ﹤0.01% 3800
2019
Q4 		$176K Buy
+12,561
New +$149K ﹤0.01% 3947

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon's CABA Position: Q2 2026 in Review

Bank of New York Mellon increased its Cabaletta Bio (CABA) stake by 461% in Q2 2026, buying an estimated $824K and bringing the position to 304,819 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

Bank of New York Mellon first reported a position in CABA in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.56M in Q4 2023. 45 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Bank of New York Mellon held 304,819 shares of Cabaletta Bio worth $948K as of Q2 2026.
  • Bank of New York Mellon bought 250,520 Cabaletta Bio shares in Q2 2026, an estimated $824K.
  • Cabaletta Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3394 holding.
  • Bank of New York Mellon first reported a position in Cabaletta Bio in Q4 2019 and has held it in 27 quarters since.
  • Bank of New York Mellon's Cabaletta Bio position peaked at $3.56M in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.